Zevra Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Zevra Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 163% to $27,461,000. Profit margin reached -168%. Total operating expenses were $74,120,000.
Profit Margin
| 2014 | 0 | -24.45M | |
|---|---|---|---|
| 2015 | 0 | -54.66M | |
| 2016 | 0 | -16.51M | |
| 2017 | 0 | -43.38M | |
| 2018 | 0 | -56.46M | |
| 2019 | 12.83M | -24.52M | -191% |
| 2020 | 13.28M | -12.76M | -96.03% |
| 2021 | 28.65M | -8.55M | -29.86% |
| 2022 | 10.45M | -41.54M | -397.24% |
| 2023 | 27.46M | -46.04M | -167.69% |
ZVRA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 27.46M | 10.45M | 28.65M | 13.28M | 12.83M | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 2.94M | 343K | 2.05M | 1.30M | 2.94M | 0 | 336K | 0 | 84K | 0 |
Gross profit | 24.51M | 10.11M | 26.59M | 11.98M | 9.89M | 0 | -336K | 0 | -84K | 0 |
Operating exp. | ||||||||||
Research and development | 39.80M | 19.61M | 10.16M | 8.84M | 19.41M | 41.75M | 20.59M | 20.47M | 13.93M | 11.91M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93 |
Total operating expenses | 74.12M | 34.95M | 18.86M | 16.76M | 30.23M | 54.26M | 33.36M | 34.47M | 22.81M | 16.44M |
Operating income | -49.60M | -24.84M | 7.72M | -4.78M | -20.33M | -55.90M | -33.36M | -37.48M | -22.81M | -16.44M |
Other income (expenses), net | 3.55M | -17.48M | -16.25M | -7.18M | -4.20M | 4.34M | -10.06M | 24.71M | -31.82M | -8.03M |
Income before tax | -46.04M | -42.32M | -8.52M | -12.79M | -24.54M | -56.59M | -43.42M | -16.53M | -54.63M | -24.47M |
Income tax expense | 0 | -786K | 34K | -34K | -22K | -126K | -43K | -15K | 26K | -22.24K |
Net income | -46.04M | -41.54M | -8.55M | -12.76M | -24.52M | -56.46M | -43.38M | -16.51M | -54.66M | -24.45M |
Earnings per share | ||||||||||
Basic EPS | -1.3 | -1.2 | -0.29 | -3.21 | -13.23 | -50.39 | -47.37 | -18.1 | -118.69 | -31.79 |
Diluted EPS | -1.3 | -1.2 | -0.29 | -3.21 | -13.23 | -50.39 | -47.37 | -18.1 | -118.69 | -31.79 |
| Data source |